Approval · Notice of Compliance 2079 · 1999
TOPAMAX: Notice of Compliance 2079
Issued May 20, 1999
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2079
- Date
- May 20, 1999
- Company
- Janssen-Ortho Inc.
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New dosage form - sprinkle capsule formulation
- Therapeutic class
- Anti-epileptic
Products in this notice
Medicinal ingredients
- TOPIRAMATE 15 MG per CAP
- TOPIRAMATE 25 MG per CAP
- TOPIRAMATE 50 MG per CAP